{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:57:31Z","timestamp":1793908651970,"version":"4.8.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82530060"],"award-info":[{"award-number":["82530060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92269204"],"award-info":[{"award-number":["92269204"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32400743"],"award-info":[{"award-number":["32400743"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41588-026-02660-5","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T09:03:49Z","timestamp":1783501429000},"page":"1891-1905","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Metabolically and epigenetically reprogrammed splenic TRNP1hiCD8+ T cells exacerbate liver fibrosis"],"prefix":"10.1038","volume":"58","author":[{"given":"Liyuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongquan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2459-3923","authenticated-orcid":false,"given":"Fu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8780-0099","authenticated-orcid":false,"given":"Ye","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2923-0729","authenticated-orcid":false,"given":"Yanfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8670-517X","authenticated-orcid":false,"given":"Jin","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"2660_CR1","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41575-024-00967-4","volume":"21","author":"LY Mak","year":"2024","unstructured":"Mak, L. Y. et al. Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions. Nat. Rev. Gastroenterol. Hepatol. 21, 834\u2013851 (2024).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2660_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41572-025-00599-1","volume":"11","author":"DQ Huang","year":"2025","unstructured":"Huang, D. Q. et al. Metabolic dysfunction-associated steatotic liver disease in adults. Nat. Rev. Dis. Primers. 11, 14 (2025).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"2660_CR3","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/j.jhep.2024.07.026","volume":"82","author":"S Liu","year":"2025","unstructured":"Liu, S., Wan, H., Yang, L., Shen, J. & Qi, X. High prevalence of steatotic liver disease and fibrosis in the general population: a large prospective study in China. J. Hepatol. 82, e23\u2013e25 (2025).","journal-title":"J. Hepatol."},{"key":"2660_CR4","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","volume":"36","author":"P Horn","year":"2024","unstructured":"Horn, P. & Tacke, F. Metabolic reprogramming in liver fibrosis. Cell Metab. 36, 1439\u20131455 (2024).","journal-title":"Cell Metab."},{"key":"2660_CR5","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jhep.2025.02.033","volume":"83","author":"GR Steinberg","year":"2025","unstructured":"Steinberg, G. R., Valvano, C. M., De Nardo, W. & Watt, M. J. Integrative metabolism in MASLD and MASH: pathophysiology and emerging mechanisms. J. Hepatol. 83, 584\u2013595 (2025).","journal-title":"J. Hepatol."},{"key":"2660_CR6","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","volume":"610","author":"A Filliol","year":"2022","unstructured":"Filliol, A. et al. Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. Nature 610, 356\u2013365 (2022).","journal-title":"Nature"},{"key":"2660_CR7","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41586-024-08317-9","volume":"637","author":"L Gu","year":"2025","unstructured":"Gu, L. et al. FBP1 controls liver cancer evolution from senescent MASH hepatocytes. Nature 637, 461\u2013469 (2025).","journal-title":"Nature"},{"key":"2660_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41590-024-02037-y","volume":"26","author":"P Zhang","year":"2025","unstructured":"Zhang, P., Watari, K. & Karin, M. Innate immune cells link dietary cues to normal and abnormal metabolic regulation. Nat. Immunol. 26, 29\u201341 (2025).","journal-title":"Nat. Immunol."},{"key":"2660_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","volume":"20","author":"L Hammerich","year":"2023","unstructured":"Hammerich, L. & Tacke, F. Hepatic inflammatory responses in liver fibrosis. Nat. Rev. Gastroenterol. Hepatol. 20, 633\u2013646 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2660_CR10","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41586-024-07630-7","volume":"631","author":"M Bosch","year":"2024","unstructured":"Bosch, M. et al. A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection. Nature 631, 867\u2013875 (2024).","journal-title":"Nature"},{"key":"2660_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adv2106","volume":"17","author":"H Shi","year":"2025","unstructured":"Shi, H. et al. Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction-associated steatohepatitis. Sci. Transl. Med. 17, eadv2106 (2025).","journal-title":"Sci. Transl. Med."},{"key":"2660_CR12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2405746121","volume":"121","author":"S Ganguly","year":"2024","unstructured":"Ganguly, S. et al. Lipid-associated macrophages\u2019 promotion of fibrosis resolution during MASH regression requires TREM2. Proc. Natl Acad. Sci. USA 121, e2405746121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2660_CR13","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1080\/17474124.2021.1914587","volume":"15","author":"G Tarantino","year":"2021","unstructured":"Tarantino, G., Citro, V. & Balsano, C. Liver-spleen axis in nonalcoholic fatty liver disease. Expert Rev. Gastroenterol. Hepatolo. 15, 759\u2013769 (2021).","journal-title":"Expert Rev. Gastroenterol. Hepatolo."},{"key":"2660_CR14","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1002\/hep.32782","volume":"77","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. CD11b+CD43hiLy6Clo splenocyte-derived macrophages exacerbate liver fibrosis via spleen-liver axis. Hepatology 77, 1612\u20131629 (2023).","journal-title":"Hepatology"},{"key":"2660_CR15","doi-asserted-by":"publisher","first-page":"e0004306","DOI":"10.1371\/journal.pntd.0004306","volume":"10","author":"M Burke","year":"2016","unstructured":"Burke, M. et al. FOXP3+ regulatory T cells in hepatic fibrosis and splenomegaly caused by Schistosoma japonicum: the spleen may be a major source of Tregs in subjects with splenomegaly. PLoS Negl. Trop. Dis. 10, e0004306 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2660_CR16","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1007\/s00535-015-1054-3","volume":"50","author":"K Tanabe","year":"2015","unstructured":"Tanabe, K. et al. Migration of splenic lymphocytes promotes liver fibrosis through modification of T helper cytokine balance in mice. J. Gastroenterol. 50, 1054\u20131068 (2015).","journal-title":"J. Gastroenterol."},{"key":"2660_CR17","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.7150\/thno.87791","volume":"14","author":"C Han","year":"2024","unstructured":"Han, C. et al. Intravital imaging of splenic classical monocytes modifying the hepatic CX3CR1+ cells motility to exacerbate liver fibrosis via spleen-liver axis. Theranostics 14, 2210\u20132231 (2024).","journal-title":"Theranostics"},{"key":"2660_CR18","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.cell.2018.02.061","volume":"173","author":"Y Han","year":"2018","unstructured":"Han, Y. et al. Tumor-induced generation of splenic erythroblast-like Ter-cells promotes tumor progression. Cell 173, 634\u2013648.e12 (2018).","journal-title":"Cell"},{"key":"2660_CR19","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","volume":"592","author":"M Dudek","year":"2021","unstructured":"Dudek, M. et al. Auto-aggressive CXCR6+CD8 T cells cause liver immune pathology in NASH. Nature 592, 444\u2013449 (2021).","journal-title":"Nature"},{"key":"2660_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24734-0","volume":"12","author":"Y Koda","year":"2021","unstructured":"Koda, Y. et al. CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells. Nat. Commun. 12, 4474 (2021).","journal-title":"Nat. Commun."},{"key":"2660_CR21","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s41575-025-01118-z","volume":"22","author":"DB Romero","year":"2025","unstructured":"Romero, D. B., Finney, G. E., Dudek, M. & Pallett, L. J. Tissue-resident memory CD8+ T cells: master deciphers of the hepatic environment. Nat. Rev. Gastroenterol. Hepatol. 22, 814\u2013828 (2025).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2660_CR22","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2013.03.027","volume":"153","author":"R Stahl","year":"2013","unstructured":"Stahl, R. et al. Trnp1 regulates expansion and folding of the mammalian cerebral cortex by control of radial glial fate. Cell 153, 535\u2013549 (2013).","journal-title":"Cell"},{"key":"2660_CR23","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1002\/jcsm.12797","volume":"12","author":"X Zeng","year":"2021","unstructured":"Zeng, X. et al. Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China. J. Cachexia Sarcopenia Muscle 12, 1948\u20131958 (2021).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"2660_CR24","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s12072-023-10497-x","volume":"18","author":"X Zeng","year":"2023","unstructured":"Zeng, X. et al. Skeletal muscle alterations indicate poor prognosis in cirrhotic patients: a multicenter cohort study in China. Hepatol. Int. 18, 673\u2013687 (2023).","journal-title":"Hepatol. Int."},{"key":"2660_CR25","doi-asserted-by":"publisher","first-page":"811","DOI":"10.21037\/hbsn-20-263","volume":"10","author":"PF Hu","year":"2021","unstructured":"Hu, P. F. et al. The presence of NAFLD in nonobese subjects increased the risk of metabolic abnormalities than obese subjects without NAFLD: a population-based cross-sectional study. Hepatobiliary Surg. Nutr. 10, 811\u2013824 (2021).","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"2660_CR26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11596-022-2666-5","volume":"43","author":"M Qu","year":"2022","unstructured":"Qu, M. et al. Increased prevalence of thyroid nodules across nearly 10 years in Shanghai, China. Curr. Med. Sci. 43, 191\u2013197 (2022).","journal-title":"Curr. Med. Sci."},{"key":"2660_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2217\/epi.11.71","volume":"3","author":"TM Hardy","year":"2011","unstructured":"Hardy, T. M. & Tollefsbol, T. O. Epigenetic diet: impact on the epigenome and cancer. Epigenomics 3, 503\u2013518 (2011).","journal-title":"Epigenomics"},{"key":"2660_CR28","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41568-019-0187-8","volume":"19","author":"SM Sanderson","year":"2019","unstructured":"Sanderson, S. M., Gao, X., Dai, Z. & Locasale, J. W. Methionine metabolism in health and cancer: a nexus of diet and precision medicine. Nat. Rev. Cancer 19, 625\u2013637 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"2660_CR29","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.jnutbio.2012.03.003","volume":"23","author":"OS Anderson","year":"2012","unstructured":"Anderson, O. S., Sant, K. E. & Dolinoy, D. C. Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. The J. Nutr. Biochem. 23, 853\u2013859 (2012).","journal-title":"The J. Nutr. Biochem."},{"key":"2660_CR30","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/s41590-025-02223-6","volume":"26","author":"P Sharma","year":"2025","unstructured":"Sharma, P. et al. Early methionine availability attenuates T cell exhaustion. Nat. Immunol. 26, 1384\u20131396 (2025).","journal-title":"Nat. Immunol."},{"key":"2660_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41571-024-00972-1","volume":"22","author":"SS Tolu","year":"2024","unstructured":"Tolu, S. S., Viny, A. D., Amengual, J. E., Pro, B. & Bates, S. E. Getting the right combination to break the epigenetic code. Nat. Rev. Clin. Oncol. 22, 117\u2013133 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2660_CR32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41586-022-05365-x","volume":"611","author":"J Xu","year":"2022","unstructured":"Xu, J. et al. Subtype-specific 3D genome alteration in acute myeloid leukaemia. Nature 611, 387\u2013398 (2022).","journal-title":"Nature"},{"key":"2660_CR33","doi-asserted-by":"publisher","first-page":"21931","DOI":"10.1073\/pnas.1016071107","volume":"107","author":"MP Creyghton","year":"2010","unstructured":"Creyghton, M. P. et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl Acad. Sci. USA 107, 21931\u201321936 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2660_CR34","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1016\/j.molcel.2024.10.042","volume":"84","author":"J Harke","year":"2024","unstructured":"Harke, J. et al. Multiple allelic configurations govern long-range Shh enhancer-promoter communication in the embryonic forebrain. Mol. Cell 84, 4698\u20134710.e6 (2024).","journal-title":"Mol. Cell"},{"key":"2660_CR35","doi-asserted-by":"publisher","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","volume":"5","author":"F Gelain","year":"2010","unstructured":"Gelain, F. et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE 5, e15004 (2010).","journal-title":"PLoS ONE"},{"key":"2660_CR36","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s41588-022-01199-5","volume":"54","author":"G Sveinbjornsson","year":"2022","unstructured":"Sveinbjornsson, G. et al. Multiomics study of nonalcoholic fatty liver disease. Nat. Genet. 54, 1652\u20131663 (2022).","journal-title":"Nat. Genet."},{"key":"2660_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2025.100611","volume":"6","author":"H Demirbilek","year":"2025","unstructured":"Demirbilek, H. et al. Global, multi-center, repeat-dose, phase 2 study of RZ358 (ersodetug), an insulin receptor antibody, for congenital hyperinsulinism. Med 6, 100611 (2025).","journal-title":"Med"},{"key":"2660_CR38","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1038\/s12276-023-01101-1","volume":"55","author":"NO Yunn","year":"2023","unstructured":"Yunn, N. O., Kim, J., Ryu, S. H. & Cho, Y. A stepwise activation model for the insulin receptor. Exp. Mol. Med. 55, 2147\u20132161 (2023).","journal-title":"Exp. Mol. Med."},{"key":"2660_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-biochem-052521-033250","volume":"92","author":"E Choi","year":"2023","unstructured":"Choi, E. & Bai, X. C. The activation mechanism of the insulin receptor: a structural perspective. Annu. Rev. Bioch. 92, 247\u2013272 (2023).","journal-title":"Annu. Rev. Bioch."},{"key":"2660_CR40","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/gutjnl-2014-307979","volume":"65","author":"O Morales-Ibanez","year":"2016","unstructured":"Morales-Ibanez, O. et al. Kinase analysis in alcoholic hepatitis identifies p90RSK as a potential mediator of liver fibrogenesis. Gut 65, 840\u2013851 (2016).","journal-title":"Gut"},{"key":"2660_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-3804-9_1","volume":"1459","author":"C Viotti","year":"2016","unstructured":"Viotti, C. ER to Golgi-dependent protein secretion: the conventional pathway. Methods Mol. Biol. 1459, 3\u201329 (2016).","journal-title":"Methods Mol. Biol."},{"key":"2660_CR42","doi-asserted-by":"publisher","first-page":"109821","DOI":"10.1016\/j.celrep.2021.109821","volume":"37","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Homocysteine inhibits pro-insulin receptor cleavage and causes insulin resistance via protein cysteine-homocysteinylation. Cell Rep. 37, 109821 (2021).","journal-title":"Cell Rep."},{"key":"2660_CR43","doi-asserted-by":"publisher","first-page":"e2403732","DOI":"10.1002\/advs.202403732","volume":"11","author":"W Su","year":"2024","unstructured":"Su, W. et al. Furin egress from the TGN is regulated by membrane-associated RING-CH Finger (MARCHF) proteins and ubiquitin-specific protease 32 (USP32) via nondegradable K33-polyubiquitination. Adv. Sci. 11, e2403732 (2024).","journal-title":"Adv. Sci."},{"key":"2660_CR44","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41569-018-0002-3","volume":"15","author":"CL Liu","year":"2018","unstructured":"Liu, C. L. et al. Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials. Nat. Rev. Cardiol. 15, 351\u2013370 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"2660_CR45","doi-asserted-by":"publisher","first-page":"7929","DOI":"10.1074\/jbc.M109.075010","volume":"285","author":"B Christensen","year":"2010","unstructured":"Christensen, B., Schack, L., Kl\u00e4ning, E. & S\u00f8rensen, E. S. Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D. J. Biol. Chem. 285, 7929\u20137937 (2010).","journal-title":"J. Biol. Chem."},{"key":"2660_CR46","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1097\/HEP.0000000000001243","volume":"82","author":"ZM Younossi","year":"2025","unstructured":"Younossi, Z. M. et al. Prevalence and predictors of cirrhosis and portal hypertension in the United States. Hepatology 82, 1229\u20131240 (2025).","journal-title":"Hepatology"},{"key":"2660_CR47","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"F Tacke","year":"2024","unstructured":"Tacke, F. et al. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J. Hepatol. 81, 492\u2013542 (2024).","journal-title":"J. Hepatol."},{"key":"2660_CR48","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00535-023-01982-z","volume":"58","author":"TM Gao","year":"2023","unstructured":"Gao, T. M. et al. Splenectomy and azygoportal disconnection decreases the risk of hepatocellular carcinoma for cirrhosis patients with portal hypertension bleeding: a 10-year retrospective follow-up study based on the inverse probability of treatment weighting method. J. Gastroenterol. 58, 503\u2013512 (2023).","journal-title":"J. Gastroenterol."},{"key":"2660_CR49","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","volume":"587","author":"NC Henderson","year":"2020","unstructured":"Henderson, N. C., Rieder, F. & Wynn, T. A. Fibrosis: from mechanisms to medicines. Nature 587, 555\u2013566 (2020).","journal-title":"Nature"},{"key":"2660_CR50","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1016\/j.cmet.2024.08.012","volume":"36","author":"P Zhang","year":"2024","unstructured":"Zhang, P. et al. IL-22 resolves MASLD via enterocyte STAT3 restoration of diet-perturbed intestinal homeostasis. Cell Metab. 36, 2341\u20132354.e6 (2024).","journal-title":"Cell Metab."},{"key":"2660_CR51","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1751-2980.2008.00331.x","volume":"9","author":"MD Zeng","year":"2008","unstructured":"Zeng, M. D. et al. Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J. Dig. Dis. 9, 108\u2013112 (2008).","journal-title":"J. Dig. Dis."},{"key":"2660_CR52","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1259\/bjr.75.895.750573","volume":"75","author":"PM Lamb","year":"2002","unstructured":"Lamb, P. M. et al. Spleen size: how well do linear ultrasound measurements correlate with three-dimensional CT volume assessments? Br. J. Radiol. 75, 573\u2013577 (2002).","journal-title":"Br. J. Radiol."},{"key":"2660_CR53","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1148\/115.1.157","volume":"115","author":"T Koga","year":"1975","unstructured":"Koga, T. & Morikawa, Y. Ultrasonographic determination of the splenic size and its clinical usefulness in various liver diseases. Radiology 115, 157\u2013161 (1975).","journal-title":"Radiology"},{"key":"2660_CR54","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee, J. H. et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig. Liver Dis. 42, 503\u2013508 (2010).","journal-title":"Dig. Liver Dis."},{"key":"2660_CR55","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.jhep.2022.03.026","volume":"76","author":"QM Anstee","year":"2022","unstructured":"Anstee, Q. M., Castera, L. & Loomba, R. Impact of non-invasive biomarkers on hepatology practice: past, present and future. J. Hepatol. 76, 1362\u20131378 (2022).","journal-title":"J. Hepatol."},{"key":"2660_CR56","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo, P. et al. The NAFLD fibrosis score. Hepatology 45, 846\u2013854 (2007).","journal-title":"Hepatology"},{"key":"2660_CR57","doi-asserted-by":"publisher","first-page":"100086","DOI":"10.1016\/j.xpro.2020.100086","volume":"1","author":"M Charni-Natan","year":"2020","unstructured":"Charni-Natan, M. & Goldstein, I. Protocol for primary mouse hepatocyte isolation. STAR Protoc. 1, 100086 (2020).","journal-title":"STAR Protoc."},{"key":"2660_CR58","first-page":"22","volume":"11","author":"KW Jia","year":"2024","unstructured":"Jia, K. W. et al. Interferon-\u03b1 stimulates DExH-box helicase 58 to prevent hepatocyte ferroptosis. Mil. Med. Res. 11, 22 (2024).","journal-title":"Mil. Med. Res."},{"key":"2660_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60920-0","volume":"16","author":"Y Zhou","year":"2025","unstructured":"Zhou, Y. et al. Stress granule assembly impairs macrophage efferocytosis to aggravate allergic rhinitis in mice. Nat. Commun. 16, 5610 (2025).","journal-title":"Nat. Commun."},{"key":"2660_CR60","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.cmet.2025.12.015","volume":"38","author":"Y Li","year":"2026","unstructured":"Li, Y. et al. Lipid-induced granules in hepatocytes alleviate liver fibrosis. Cell Metab. 38, 746\u2013762.e10 (2026).","journal-title":"Cell Metab."},{"key":"2660_CR61","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13045-022-01381-6","volume":"15","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. JMJD4-demethylated RIG-I prevents hepatic steatosis and carcinogenesis. J. Hematol. Oncol. 15, 161 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"2660_CR62","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/hep.32487","volume":"77","author":"Y Zhou","year":"2023","unstructured":"Zhou, Y. et al. Malignant progression of liver cancer progenitors requires lysine acetyltransferase 7-acetylated and cytoplasm-translocated G protein G\u03b1S. Hepatology 77, 1106\u20131121 (2023).","journal-title":"Hepatology"},{"key":"2660_CR63","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1053\/j.gastro.2025.08.022","volume":"170","author":"M Wang","year":"2026","unstructured":"Wang, M. et al. Clusterin drives fiber endocytosis by mesothelial cells to resolve liver fibrosis. Gastroenterology 170, 569\u2013583 (2026).","journal-title":"Gastroenterology"},{"key":"2660_CR64","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"2660_CR65","doi-asserted-by":"publisher","first-page":"105688","DOI":"10.1016\/j.ebiom.2025.105688","volume":"115","author":"N Sasamoto","year":"2025","unstructured":"Sasamoto, N. et al. Prospective evaluation of plasma proteins in relation to surgical endometriosis diagnosis in the Nurses\u2019 Health Study II. eBioMedicine 115, 105688 (2025).","journal-title":"eBioMedicine"},{"key":"2660_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02317-2","volume":"9","author":"Z Zhu","year":"2018","unstructured":"Zhu, Z. et al. Causal associations between risk factors and common diseases inferred from GWAS summary data. Nat. Commun. 9, 224 (2018).","journal-title":"Nat. Commun."},{"key":"2660_CR67","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1126\/science.1262110","volume":"348","author":"GTEx Consortium.","year":"2015","unstructured":"GTEx Consortium. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648\u2013660 (2015).","journal-title":"Science"},{"key":"2660_CR68","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ng.3162","volume":"47","author":"A Buil","year":"2014","unstructured":"Buil, A. et al. Gene-gene and gene-environment interactions detected by transcriptome sequence analysis in twins. Nat. Genet. 47, 88\u201391 (2014).","journal-title":"Nat. Genet."},{"key":"2660_CR69","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad, E. et al. Large-scale integration of the plasma proteome with genetics and disease. Nat. Genet. 53, 1712\u20131721 (2021).","journal-title":"Nat. Genet."},{"key":"2660_CR70","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329\u2013338 (2023).","journal-title":"Nature"},{"key":"2660_CR71","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/s41586-023-06034-3","volume":"617","author":"E Pairo-Castineira","year":"2023","unstructured":"Pairo-Castineira, E. et al. GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19. Nature 617, 764\u2013768 (2023).","journal-title":"Nature"},{"key":"2660_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53621-7","volume":"15","author":"X Wu","year":"2024","unstructured":"Wu, X. et al. Transcriptome-wide Mendelian randomization during CD4+ T cell activation reveals immune-related drug targets for cardiometabolic diseases. Nat. Commun. 15, 9302 (2024).","journal-title":"Nat. Commun."},{"key":"2660_CR73","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ccr.2011.01.001","volume":"19","author":"J Hou","year":"2011","unstructured":"Hou, J. et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a\/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19, 232\u2013243 (2011).","journal-title":"Cancer Cell"},{"key":"2660_CR74","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ccr.2013.11.011","volume":"25","author":"J Hou","year":"2014","unstructured":"Hou, J. et al. Hepatic RIG-I predicts survival and interferon-alpha therapeutic response in hepatocellular carcinoma. Cancer Cell 25, 49\u201363 (2014).","journal-title":"Cancer Cell"},{"key":"2660_CR75","doi-asserted-by":"publisher","unstructured":"Zhang, L. Metabolically and epigenetically reprogrammed splenic TRNP1hiCD8+ T cells exacerbate liver fibrosis. Zenodo https:\/\/doi.org\/10.5281\/zenodo.20001905 (2026).","DOI":"10.5281\/zenodo.20001905"}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41588-026-02660-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-026-02660-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-026-02660-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T22:03:35Z","timestamp":1786053815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41588-026-02660-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":75,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2660"],"URL":"https:\/\/doi.org\/10.1038\/s41588-026-02660-5","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}